Small Cap Value Report (Tue 19 April 2022) - D4T4, CBOX, CER
Good morning, it's Paul here with the SCVR.
Agenda -
D4t4 Solutions (LON:D4T4) (I hold) - a reassuring trading update for FY 3/2022, and confident outlook. It has a particularly strong balance sheet too. With hindsight, the valuation probably got a bit frothy last year. It's since dropped a lot (like almost all small caps) and now looks a decent company, on a more reasonable valuation.
Cake Box Holdings (LON:CBOX) - a reassuring trading update from this rapidly expanding franchise business for fresh cakes. Valuation is cheap, because the market choked on revelations from the outgoing auditor last year. Is it time to forgive & forget, now a new CFO is in place, and tightening up financial controls? Possibly, but I can't decide.
Cerillion (LON:CER) - an impressive half year update today. It's in line with expectations, but reading between the lines, I reckon the company looks set to beat forecasts. very impressive growth, and cash is pouring in. Valuation looks reasonable. I like this a lot.
Explanatory notes -
A quick reminder that we don’t recommend any stocks. We aim to review trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.
We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).
A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed - please be civil, rational, and include the company name/ticker, otherwise people won't necessarily know what company you are referring to
Paul’s Section:
D4t4 Solutions (LON:D4T4) (I hold)
230p (pre market open)
Market cap £92m
D4t4 Solutions Plc (AIM: D4T4, "the Group", "D4t4"), the AIM-listed data solutions provider, announces the following trading update for the year ended 31 March 2022.
FY 3/2022 revenues are in line with expectations (£24.3m forecast, per Finncap, Feb 2022)
Adj Profit Before Tax (PBT) at upper end of market expectations.
Annual Recurring Revenues rose 32% to £14.0m, so about 58% of total revenues - a solid base, so this should reduce lumpiness of licence wins seen in the past.
Results due out in mid- July.
Confident outlook -
The Board remains highly confident in the Group's strategy, and we start the new financial year with a strengthened management team, good revenue visibility, and a strong pipeline of opportunities across both the Celebrus Customer Data Platform (CDP) and Fraud Data Platform (FDP) products. We expect to announce further contract wins in the coming months.
My opinion - in common with almost all UK small caps, the share price has drifted down a lot from last year’s peak of almost 400p. It’s now only 230p.
Is it a bargain then? Not really, if you use a PER multiple. Forecast EPS is only 5.6p for FY 3/2022 (PER of 41), which would represent the third consecutive year of falling earnings. Although the strategy has been targeting top line growth, which required increased overheads to achieve it. Hence no surprises here, with today’s in line update.
EDIT: many thanks to Finncap for an update note that's just come through on my email. It's increasing forecast EPS from 5.6p to 6.9p for FY 3/2022. Finncap leaves its FY 3/2023 forecast at 9.8p. Finncap also stresses the very good point that transitioning to SaaS model suppresses top line growth for a number of years, but results in a better, more predictable business in the future. The growth in ARR of 32% is a more realistic picture of underlying growth, a great point, and this makes the shares look more attractive than the headline numbers suggest. End of edit.
Forecast for FY 3/2023 is a 75% rise in EPS to 9.8p, quite a tall order, and if achieved the PER would not be cheap at 23.5 times.
Checking the last balance sheet, it’s outstandingly good. There was a cash pile (which looks like surplus cash, i.e. not offset by deferred income, as is often the case with software companies) of about £16m. That’s about 17% of the market cap, so we could adjust the PERs down by that figure, which makes the valuation look more reasonable.
The main attraction for me of this share, is that it seems to operate in a very interesting & growing niche in data analytics, and is winning big clients. So the hope is that growth could accelerate, and potentially deliver a greater valuation, or a premium-priced takeover bid perhaps?
In the meantime, I think the valuation can be justified on fundamentals, with the speculative froth in last year’s price (with hindsight) having gone. That makes it more attractive in my eyes, now that we can buy it more cheaply. If it continues falling, I’d be looking to top up my position.
.
Cake Box Holdings (LON:CBOX)
192p (pre market open)
Market cap £77m
Cake Box Holdings plc, the specialist retailer of fresh cream cakes, is pleased to announce a full year trading update for the 12 months ended 31 March 2022.
The background here is that the share price has been particularly battered by the auditor resigning, and taking the unusual step of writing to shareholders pointing out a number of areas of concern. The performance & conduct of the former CFO seems particularly bad - in dumping a large number of shares days before the auditor resigned, having poor financial controls, and not being open with the auditors, which is appalling really, and does taint the company.
Anyway, he’s now gone, and sensible changes have been made, which I covered here in March.
Today’s update starts with a buoyant-sounding headline -
Continued sustainable growth with an exceptional year for store openings
Impressive growth indeed - helped by soft comparatives from lockdown 1, but still impressive underlying growth -
Trading during the second half has continued to be strong across the Group's store estate and online delivery channels. Accordingly, the Group expects to report revenues for the year as up c.50% year-on-year, with adjusted profit before tax in line with market expectations.
New sites - this is noteworthy, with CBOX accelerating the pace of expansion, 31 new shops opened in the year, bringing the total to 185. Kiosks are also being rolled out, with 35 now operating (e.g. within ASDA).
Pipeline - deposits are held for a further 53 new sites, so this is an impressively rapid expansion, via franchisees, who take on the risk, and capex - a very nice business model for CBOX.
Net cash - is £5.2m. I think the balance sheet looks OK, assuming the former CFO wasn’t fiddling the figures.
My opinion - if it hadn’t been for the accounting problems, then this share would look remarkably good value now, for a rapid roll-out of a proven format. Stockopedia is showing a forward PER of only 11.9, and a 4% dividend yield.
Can we trust the numbers though? Playing it safe, it might be best to wait for the new auditors to review & approve the FY 3/2022 numbers before investing here.
That might mean missing out on a bargain though, so I’m torn on what to do.
As previously mentioned, the major shareholders seem to almost all be trying to sell! That suggests to me a potentially lengthy process for institutional shareholdings to be sold down, and find new owners, probably private investors. This is a structural problem with UK small caps - brokers tend to float new companies by placing shares in large blocks with institutions. Then there’s a lack of liquidity. If something happens to shatter the confidence of institutions (which is what happened at CBOX), then who are the institutions going to sell to? The risk is that it takes a very long time for institutions to dribble out their shares in the market, creating a permanent overhang, limiting the share price from recovering. The only solution is for the share price to fall so low, that new investors find it irresistible in numbers large enough to clear the overhang.
The upside is that confidence might return over time, with a new CFO now in place.
It does seem a fundamentally good business, and rapidly expanding. So it might be worth taking a small initial position here, and then monitor how things progress. I can’t make up my mind. It’s cheap, but for a good reason! IF there hadn’t been these audit problems, then I reckon the share price would be about 50% higher than it is now.
.
Cerillion (LON:CER)
795p (up 4% at 11:41)
Market cap £235m
Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the first six months of its current financial year ending 30 September 2022.
Record Six Months
“Very strong” H1 trading - new records for revs & EBITDA.
H1 revenues £16.1m, up 26% vs LY.
H1 adj EBITDA up 48% to £7.1m
Net cash up 114% to £16.5m
Sales pipeline remains strong.
Confident that FY 9/2022 will achieve company expectations (which are usually the same as market expectations, so why not say so, instead of introducing uncertainty?)
H1 results due out in mid-May.
Positive outlook -
"The business has delivered a record performance for any six-month period, driven by our backlog of new customer implementations and strong demand from existing customers. The market backdrop remains highly favourable for Cerillion. With a strong pipeline of new business, we remain well-placed for continuing growth this financial year and next."
Valuation - as we know, growth/tech valuations have plunged in the last year. CER dipped down to 600p, but has shot back up again recently - fully justified by today’s excellent update, in my view.
Liberum has issued a helpful update note today, with forecast EPS of 28.4p for this year (FY 9/2022). This is a bit below Stockopedia’s consensus forecast of 30.2p. Since Liberum comments that it sees upside on its lower forecast, then I’m happy to work on c.30p EPS current year earnings, and maybe a beat against that, and possibly closer to 40p next year.
Hence we’re looking at a PER of about 20 times next year’s earnings. That’s certainly not expensive, for one of the best growth companies in the small caps space.
My opinion - performance at Cerillion has been outstanding for several years now. Providing growth can be maintained, then this share looks really attractive, as a long-term tuck away and forget. So it gets a thumbs up from me.
.
Disclaimer
This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.


38 comments
Cracking business which has not put a foot wrong since its IPO. I am always astonished by the detail available in my phone bills, which is what CER is all about.
Looking at the three main UK solar funds Bluefield Solar Income Fund (LON:BSIF) Foresight Solar Fund (LON:FSFL) Nextenergy Solar Fund (LON:NESF) does anyone have any thoughts as to what the main differences are.
They all pay a similar Div (6%-7.5%), are all similar mkt cap (£600m+), but have varying discounts/premiums - lowest being 0.7% discount for Nextenergy Solar Fund (LON:NESF) through to 7.5% premium for Bluefield Solar Income Fund (LON:BSIF)
Their performances have been pretty similar and very hard to differentiate across 3 & 5yr periods.
Does anyone have any reasoning for their preferences?
I am going to look into them in a bit more detail, but before I do that does anyone know of anything specific.
Hi KevinS1, agree with you that the similarities between these solar energy funds are greater than the differences.
I only hold Nextenergy Solar Fund (LON:NESF) of the 3 you mention and my reasoning was (a) price = NAV so why pay a premium for the others, (b) management seem credible and effective, and (c) the move into energy storage, which I think will be a big theme over the next few years. I also hold Gresham House Energy Storage Fund (LON:GRID) for the same reason.
This is an area I've always meant to look at in more detail too, as surely has to be a good sector in this environment. Nextenergy Solar Fund (LON:NESF) certainly looks attractive versus the others you mention, with a solid track record, 7% dividend yield and well diversified portfolio.
Without doing further research, I suspect it could be the NAVs are all calculated slightly differently (eg using different assumptions and discount rates) - perhaps the other funds use slightly more prudent assumptions and hence warrant an additional premium? Would be interested if you manage to find out anything further in your research.
Please let us know what you discover and decide.
Hi KevinS1,
The devil is in the detail of what they actually own, and which subsidy regime their solar farms fall under. Generally, the earlier a solar farm was built, the higher the subsidies (usually for 25 years), and this may explain the differences in discount/premium for apparently similar companies. I think that Bluefield Solar Income Fund (LON:BSIF) was the first mover.
Hi KevinS1
If you do a Stocko compare of the three Nextenergy Solar Fund (LON:NESF) Bluefield Solar Income Fund (LON:BSIF) £FSFL which you may have already done, then Foresight Solar Fund (LON:FSFL) is the winner leading 25/36
But, take note the Stock Compare is a very broad based test and often is too simplistic, but its quite useful to eyeball the three listed against each other to see the variations across the 36 tests.
I do not hold any nor have I ever looked at any of these before. I might look deeper though.
Regards
Howard
Just further on this, there is a 39 page broker note from Cenkos (available on Research Tree) which covers Nextenergy Solar Fund (LON:NESF) in some detail. Having a quick flick through, it notes that the three funds are pretty similar in terms of how they calculate NAV, although NESF has lower sensitivity to movements in power prices due to hedging - this has proved helpful for most of the time since IPO due to declining power prices, but could be a short term headwind due to recent spike in power prices. That could explain part of the discount versus its peers.
I held Cake Box Holdings (LON:CBOX) for a while on the last run up and made modest profit. I sold because I hated the fact that customer reviews for the product itself were not good. Just taken another look and they've got worse. Trust pilot has them at about 2.5.
There may be money to be made trading this stock short to medium term, but how do you have a long term success if your clientele think your product is rubbish? I'm looking for things to buy and hold and I just can't convince myself to buy back, despite looking more like 'value'.
Cake Box Holdings (LON:CBOX)
I am surprised at the TrustPilot feedback as a couple of visits to my local outlet have been positive. Good, well presented product, clean environment and an enthusiastic person in charge. Most of the customers appeared to be returnees.
I order how much control ‘head office’ has over the franchised outlets and their product and would be interested if anyone has info on this. Of course, any franchisee will not last long if they are not up to scratch…but could damage the brand name.
RE: Cake Box Holdings (LON:CBOX)
I order how much control ‘head office’ has over the franchised outlets and their product and would be interested if anyone has info on this.
Interview with the CEO, worth a listen:
https://open.spotify.com/episo...
timarr
Cake Box Holdings (LON:CBOX)
Thanks timarr.
I could be very wrong about this but the story at Cake Box Holdings (LON:CBOX) seems more like a cock-up than a conspiracy to me. It smells like a company growing too fast for the abilities of the management team to get on top of the issues arising. These are fixable issues that shouldn't derail the company so long as the cash flow is not fraudulent and I don't believe it is. I don't wish to belittle the concerns raised (hats off to Maynard Paton). Some of the mistakes are appalling and anyone investing shouldn't be surprised if the new CFO uncovers some more, but it looks to me for now that the company can ride through this. Recent prices have seemed to me to be worth accumulating at.
Director dealings can be informative around this type of issue. Paul correctly highlights the sale by the ex-CFO, but it is worth pointing out that he still owns 5% of the company and says: "I remain passionate about Cake Box and a supportive shareholder". If the evidence on that changes, my position would do too.
Cerillion (LON:CER) I’ve been buying in the last month as I like the progress confirmed this morning. Bought small, final tranche at open.
Cake Box Holdings (LON:CBOX) I nibbled before the TU and took another nibble this morning. Position is half-sized which feels about right for now. I’m working on the assumption (hope?) that the accounting issues are more about the transition to plc with the attendant demands and expectations than anything more sinister.
I can elaborate on my reasoning later from my own experience of adjusting post-IPO if anyone is interested (or not)? Busy until mid-afternoon.
Hi BnB, please do elaborate.
Hi BnB, please do elaborate.
Re Cake Box Holdings (LON:CBOX) - I’m sure Paul and others with similar experience can chip in with better, and more accounting-focused observations. And I could be completely WRONG. But my intuition on the slapdash accounting is that it stems from the evolution of the business rather than from a fraudulent intent.
It’s important to remember that entrepreneurs are often motivated by the desire for independence and self-realisation ahead of financial gain. After all, success in the former ambition usually takes care of the latter. And successful SMEs evolve haphazardly more than they are professionally planned, with the original entrepreneur(s) playing an outsized role. This tends to result in the creation of a personal fiefdom where the business becomes a vehicle for the entrepreneur’s needs, and possibly ego. This is not necessarily bad for the business as the owner’s and the company’s needs are well-aligned. But it is very common, even in the most profitable businesses, for the accounting procedures to be lightweight. After all, who needs cash flow forecasts when the business is printing money and the owner has a strong feel for the performance of debtors and solvency? Indeed, who cares about a trial balance when everything is going fine?
I can personally vouch for the fact that a business can be built to an eight figure valuation - and sale - over a number of years without employing anyone in “accounts” and without recourse to outside help - audits aside. That means no budgets, cash flow forecasts or even rudimentary attention to the balance sheet, so long as the financial characteristics of the enterprise - asset light, fast-growing, highly profitable, cash generating - are propitious and the owner has a strong, if unconventional, grasp of the numbers
And that, in my view, likely very much describes Cakebox before it’s IPO. The features that make the company attractive as an investment are the same qualities which enabled it to flourish without more professional accounting procedures. This professional deficit is then compounded by the understandable difficulties experienced by entrepreneurs who transition at IPO from lords of all they survey to servants of institutional and private shareholders. It is not unusual for existing directors to underestimate the shift required in mindset and, more pertinently, procedures. It is my best guess is that the CFO ran up against these difficulties and, when challenged by the auditors, became obstructively defensive about the slapdash nature of the record-keeping. When you have been in complete charge for a decade and suddenly these impertinent outsiders dare to make demands of you - requests that you consider superfluous given the health of the business - it can be hard not to show irritation.
It’s certainly reasonable to question the timing of the CFOs share disposals, but they could be explained by the very attractive price in the market at the time as much as other theories. And I repeat. I could be completely wrong! A possibility reflected in my only half-sized stake. But I take comfort from the measures enacted so far. The departure of the CFO and his replacement by a seasoned practitioner with a more professional background is of real comfort. Frankly, I expect new deficiencies to come to light when the replacement CFO gets his feet under the table. But, provided these are not fraudulent, they might continue the necessary evolution of the company from entrepreneurial to shareholder-focused. That is my hope and best guess. For absolute conviction, I shall need more data and await the next audited numbers with interest.
Hi BnB, thank you - very interesting and there is certainly no substitute for personal experience.
With Corero Network Security Corero Network Security (LON:CNS) (I hold) down 14% today I assume there must have been some negative weekend commentary - can anyone point me to it?
Today's update from Iofina (LON:IOF) is good news: (Spotted thanks to Mr Contrarian's invaluable updates)
" ... Iofina Chemical's iodine derivatives are in high demand and is currently
working on enhancements to improve efficiencies and increase capacities for
certain iodine and non-iodine products. Additionally, Iofina Chemical
expects to complete a laboratory upgrade in Q2 that will improve the Company's
R&D capabilities. Lastly, the Group is working with its current lending partner on terms to
extend its Revolving Line of Credit and other items to expedite growth
opportunities."
Commenting, President and CEO Dr. Tom Becker, stated: "The market continues to
move in our favour with the ongoing strong demand for our products and iodine
prices rising to $60/kg and above, a trend we expect to continue over the
course of the year. We are encouraged to see that our oil and gas partners are now reinvesting in
their assets in order to increase production on the back of the higher oil and
gas prices. We are also pleased to confirm that good progress has been made on IO#9
location and construction. We expect the final agreements to be executed very
soon and we will confirm this to the market as soon it is completed."
I have just invested, as it seems they are in a market that may keep ahead of general inflation. I'm hoping they may be another share where a strong rise in StockRank precedes a similar rise in share price.
Re Iofina (LON:IOF) my immediate thought was that "certain iodine products" is a reference to potassium iodide tablets for treating radiation exposure so not so sure about that increased demand being good news. Hopefully they have other more positive markets but it's not easy to tell from their website,
I doubt that tablets for radiation protection is a significant market for Iofina (LON:IOF) ! Iodine has many commercial uses. For example, iodide salts are used in pharmaceuticals and disinfectants, printing inks and dyes, catalysts, animal feed supplements and in medical xray imaging. Iodine is also used to make polarising filters for LCD displays and an iodide is added in small amounts to table salt, for thyroid health.
I looked to invest a few months back but read they piggy back oil/gas production so was a little put off..with the medium term seeming to support oil/gas, then its worth another look, although it had a big price jump about four months ago...its done pretty well since! Share dilution a slight worry for me.
Any thoughts on the majority of large shareholders being individuals rather than institutions?
@turbo. re Iofina (LON:IOF) major investors
Sneller seems to be a professional investor and previous head of a Ballie Gifford fund.
David Newlands and Monique Newlands seem to be professional investors: see https://www.investegate.co.uk/...
Jeffrey Ploen is non-exec Deputy Chairmen of Iofina (LON:IOF) according to their website though this appears to be unknown to Stockopedia.
Aaron Banks has appeared in newspaper reports as a wealthy individual who supported Brexit.
Lance Bailer is Iofina's non-exec Chairman.
... ... follow the money?
Morning Paul/Jack - would either of you have the time to have a quick look at Deepverge (LON:DVRG), please (I hold)?
This is small(ish) pharma company @ c.£33m Mkt Cap, which specialises in skin and water testing technology. TPI provide detailed and regular broker updates on this company but, the (financial) data does not feed through to Stocko and I would appreciate you thoughts on why we don’t see these broker forecasts on here as much as your thoughts on the company.
Many thanks.
Yes that would be appreciated, as £DEEP is one of my main investments (sadly the SP haS dropped OVER THE KAST 12 months. Many thanks.
apologies for appalling typos -am on a train - meant to say £DVRG.
Hi Chris,
I'e had a quick look at the update today from Deepverge (LON:DVRG) - reporting very strong revenue growth in Q1. The rest of the narrative is all about operational developments, and it means nothing to me.
Historically it's generated significant losses every year. We tend to steer away from speculative, small, loss-making, jam tomorrow stuff here, as there's not really anything factual to report on, whilst a business is loss-making.
It's all down to whether investors/punters think the products will take off or not, which I wouldn't want to speculate on.
As regards broker forecasts, I understand that the problem is difficulty in the data provider getting hold of all broker research. So, especially at the smaller company end, there are inevitably going to be gaps, as some brokers actively withhold their research.
Regards, Paul.
Thanks, Paul - I appreciate your response.
So, if I read what you are saying correctly about broker research, Turner Pope (in this instance) are withholding their forecast data from Stockopedia and that is why information is blank when you call up this share (stocko suggests there are no brokers; no eps forecasts of future FY numbers)?
The reason I ask is that their research/forecast papers has all this information but this isn’t displayed on Stocko.
Kind regards,
Chris
No comments yet on Cerillion (LON:CER), but well worth a look, as powering ahead.
Cerillion (LON:CER) is next on my agenda!
Thank you for bringing Cerillion to my attention - added it to my watch list.
Same, on my watch list...nice company, nice smooth growth, looks a bit pricey but will watch it, be a good one for a sudden market dip.
Rockhopper Exploration (LON:RKH) Signed agreement to develop the Sealion oil field in the Falkland.
Also-
On 28 March 2022, the Company received the following update from the Chairman
of the Panel considering the Ombrina Mare arbitration:
"The Tribunal anticipates that the proceedings will be closed in the next few weeks."
Should see a nice rise in the sp today.
Supreme (LON:SUP)
On Tuesday 12th the company issued a trading update and the sp ended 17% down. There was a good debate here and the majority thought it was an over-reaction as inflationary costs were already known about.
Paul wrote "...a strong performance for FY 3/2022 is reported. Shares are down 18% today on a mild profit warning for FY 3/2023, due to higher costs (hardly surprising). Broker forecastfor FY 3/2023 is reduced by 8%, and a lovely yield of 4.7% is forecast. This share looks good value now, so I give it a thumbs up".
For those who missed it due to the long weekend The company put out a RNS at noon on Maundy Thursday announcing a presentation this Friday (22nd). You can register here: https://www.equitydevelopment....
I cannot remember a PI presentation on a trading update before and most are announced either before or with results, rarely two days later. I suspect the company directors were also shocked by the extent of the sp fall and that this presentation is a reaction to it.
Should be interesting.